Lakeview Regional Medical Center, a campus of Tulane Medical Center, has promoted Tilly Gard to its trauma program director role.
Gard has been with Lakeview Regional since 2012, serving most recently as trauma program manager. Under her leadership, Lakeview Regional achieved the first Level III ACS Trauma Verification in the state with no deficiencies. Gard earned prior clinical experience from hospitals all over the southeastern region of Louisiana.
The Louisiana Department of Health (LDH) and Louisiana Public Health Institute (LPHI) are hosting a series of tele-town halls called Protecting our Communities from the Flu & COVID-19. Each event will be moderated by Earl Benjamin-Robinson, MD, deputy director of LDH’s Office of Community Partnerships & Health Equity; Joynetta Bell Kelly, associate deputy director of LDH’s Office of Community Partnerships & Health Equity; and Shelina Davis, CEO of LPHI. Local panelists will include each region’s medical director, faith-based leaders, and community physicians.
Louisiana Healthcare Connections announced that six community-based organizations have been awarded funding through the health plan’s COVID-19 Recovery Grants Program. The COVID-19 Recovery Grants Program awards grants of up to $5,000 each to assist eligible organizations in implementing innovative solutions to address the social service and healthcare needs of those affected by the COVID-19 pandemic.
Organizations selected for funding awards include:
• Center for Employment Opportunities, in New Orleans, for its workforce development program
St. Tammany Health System has once more received top marks nationally in Healthgrades’ annual performance evaluations of nearly 4,500 hospitals nationwide, earning five-star recognition for pacemaker procedures, as well as for treatment of respiratory failure, stroke, hip fractures, and pneumonia.
The U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization. Veklury should only be administered in a hospital or in a healthcare setting capable of providing acute care comparable to inpatient hospital care. Veklury is the first treatment for COVID-19 to receive FDA approval.
